100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NUR 2060 Lecture 1 (1). $7.99   Add to cart

Exam (elaborations)

NUR 2060 Lecture 1 (1).

 1 view  0 purchase
  • Course
  • Institution

NUR 2060 Lecture 1 (1).

Preview 1 out of 3  pages

  • July 22, 2024
  • 3
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers
avatar-seller
NUR 2060 Lecture 1
pharmacology - ANS-study of drugs and their interaction with living system or the scientific study
of all aspects of drugs including their source, uses actions, and effects

Pharmacotherapeutics - ANS-use of drugs to dx, prevent, or treat disease or to prevent
pregnancies

Properties of drugs - ANS-Effectiveness, safety, selectivity, reversible action, predictability, ease
of administration, freedom from drug interactions, low cost, chemical stability, possession of
simple generic name.

Federal Pure Food and Drug Act - ANS-free of adulterants. Very weak Act as no safety or
effectiveness requirement

FDA Food, Drug Cosmetic Act - ANS-mandated testing in animals before drugs could be sold to
humans. Many deaths from untested solvents prior to this. First Act for safety

Harris-Kefauver Ammend - ANS-Additional Safety & Effectiveness (thalidomide tragedy). First
law demand that drug actually offer benefits

Controlled Substances Act - ANS-Created 5 Schedules

Drug Regulation & Reform Act (1978) and Prescription Drug User Fee Act (1992) - ANS-Fast
track-created for AIDS drugs and cancer drugs now include drugs for other serious and life
threatening illnesses

Nursing process 5 steps - ANS-assessment, analysis, planning, implementation, and evaluation.

Drug Price Competition Act - ANS-made it easier for generic drugs to enter the market

Food and drug Administration Modernization Act - ANS-Expanded fast track: more diseases
6 months warning if D/C drug
Database kept on experimental drugs
May advertise to MD's "off label" uses

FDA Amendments Act - ANS-Drug monitoring by FDA AFTER approval

Best Pharmaceuticals for Children Act (BPCA) 2002
Pediatric Research Equity Act (2003) - ANS-Drug safety and efficacy in children
Requires pediatric clinical trials on old and new meds

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller lydiaomutho. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $7.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72964 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$7.99
  • (0)
  Add to cart